Earnings Feed
Start Free
|4May 28, 7:02 PM ET

PHARMACYCLICS INC 4

4 · PHARMACYCLICS INC · Filed May 28, 2015

Insider Transaction Report

Form 4
Period: 2015-05-26
PHARMACYCLICS INCPCYC
Clark Kenneth A
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−192→ 0 total
    Exercise: $108.44Exp: 2024-01-02→ Common Stock (192 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $95.08Exp: 2024-05-09→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−194→ 0 total
    Exercise: $107.42Exp: 2024-04-01→ Common Stock (194 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−159→ 0 total
    Exercise: $139.89Exp: 2023-10-01→ Common Stock (159 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−284→ 0 total
    Exercise: $115.80Exp: 2024-10-01→ Common Stock (284 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−134→ 0 total
    Exercise: $61.44Exp: 2023-01-02→ Common Stock (134 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−245→ 0 total
    Exercise: $85.39Exp: 2023-07-01→ Common Stock (245 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−367→ 0 total
    Exercise: $89.58Exp: 2024-07-01→ Common Stock (367 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−264→ 0 total
    Exercise: $124.46Exp: 2025-01-02→ Common Stock (264 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−15,000→ 0 total
    Exercise: $49.00Exp: 2022-11-09→ Common Stock (15,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−280→ 0 total
    Exercise: $79.67Exp: 2023-04-01→ Common Stock (280 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $74.48Exp: 2023-05-09→ Common Stock (3,750 underlying)
Footnotes (1)
  • [F1]Pursuant to terms of the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie this option was cancelled in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION